Program for managing knee osteoarthritis in primary care
Risk Assessment and Management Program (RAMP) on Knee Osteoarthritis in Primary Care- a One-year Pragmatic Randomized Controlled Trial
This study is testing a new support program for adults with knee osteoarthritis to see if it helps reduce pain and improve their daily activities compared to regular care.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 228 (estimated) |
| Ages | 45 Years and up |
| Sex | All |
| Sponsor | Chinese University of Hong Kong Academic / other |
| Locations | 1 site (Hong Kong) |
| Trial ID | NCT06283147 on ClinicalTrials.gov |
What this trial studies
This clinical trial evaluates the effectiveness of a Chronic Care Model called the Risk Assessment and Management Program on Knee Osteoarthritis (RAMP-Knee OA) in adults suffering from knee osteoarthritis. Participants will be randomly assigned to either the RAMP-Knee OA group, which includes structured support and consultations, or a usual care group. The study will assess various outcomes, including pain relief and improvements in physical function and quality of life, over a 52-week period. Participants will undergo assessments at baseline, and at 16, 32, and 52 weeks to measure the program's impact.
Who should consider this trial
Good fit: Ideal candidates are adults diagnosed with moderate to severe knee osteoarthritis and experiencing significant pain.
Not a fit: Patients with serious knee pathologies, previous knee replacements, or those unable to participate reliably may not benefit from this program.
Why it matters
Potential benefit: If successful, this program could significantly improve pain management and quality of life for patients with knee osteoarthritis.
How similar studies have performed: Previous studies utilizing Chronic Care Models have shown promise in managing chronic conditions, suggesting potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosis of Knee OA based on clinical criteria of the American Rheumatology College * Moderate to severe Knee pain for 3 months or longer (average score of 4 or greater on a 0-10 pain scale in the past 3 months) Exclusion Criteria: * Participants with potential serious knee pathology (e.g. inflammatory arthritis, acute trauma, malignancy) * Previous Knee replacement * Scheduled knee joint replacement surgery within 1 year * Participants who are unable to reliably participate (e.g. those who do not speak Chinese or unable to attend study intervention)
Where this trial is running
Hong Kong
- Lek Yuen GOPC — Hong Kong, Hong Kong (Recruiting)
Study contacts
- Principal investigator: Regina Wing Shan SIT, M.D. — Jockey Club School of Public Health and Primary Care, Chinese University of Hong Kong
- Study coordinator: Cheryl Lok Chee Fung, Bachelor
- Email: cheryllcfung@cuhk.edu.hk
- Phone: 2609 5050
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.